Literature DB >> 16339923

Hexosamines, insulin resistance, and the complications of diabetes: current status.

Maria G Buse1.   

Abstract

The hexosamine biosynthesis pathway (HBP) is a relatively minor branch of glycolysis. Fructose 6-phosphate is converted to glucosamine 6-phosphate, catalyzed by the first and rate-limiting enzyme glutamine:fructose-6-phosphate amidotransferase (GFAT). The major end product is UDP-N-acetylglucosamine (UDP-GlcNAc). Along with other amino sugars generated by HBP, it provides essential building blocks for glycosyl side chains, of proteins and lipids. UDP-GlcNAc regulates flux through HBP by regulating GFAT activity and is the obligatory substrate of O-GlcNAc transferase. The latter is a cytosolic and nuclear enzyme that catalyzes a reversible, posttranslational protein modification, transferring GlcNAc in O-linkage (O-GlcNAc) to specific serine/threonine residues of proteins. The metabolic effects of increased flux through HBP are thought to be mediated by increasing O-GlcNAcylation. Several investigators proposed that HBP functions as a cellular nutrient sensor and plays a role in the development of insulin resistance and the vascular complications of diabetes. Increased flux through HBP is required and sufficient for some of the metabolic effects of sustained, increased glucose flux, which promotes the complications of diabetes, e.g., diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase in cardiomyocytes and induction of TGF-beta and plasminogen activator inhibitor-1 in vascular smooth muscle cells, mesangial cells, and aortic endothelial cells. The mechanism was consistent with enhanced O-GlcNAcylation of certain transcription factors. The role of HBP in the development of insulin resistance has been controversial. There are numerous papers showing a correlation between increased flux through HBP and insulin resistance; however, the causal relationship has not been established. More recent experiments in mice overexpressing GFAT in muscle and adipose tissue or exclusively in fat cells suggest that the latter develop in vivo insulin resistance via cross talk between fat cells and muscle. Although the relationship between HBP and insulin resistance may be quite complex, it clearly deserves further study in concert with its role in the complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16339923      PMCID: PMC1343508          DOI: 10.1152/ajpendo.00329.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  89 in total

Review 1.  Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.

Authors:  L Wells; K Vosseller; G W Hart
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

Review 2.  New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

Authors:  A R Saltiel
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 4.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  Free fatty acids induce peripheral insulin resistance without increasing muscle hexosamine pathway product levels in rats.

Authors:  C S Choi; F N Lee; J H Youn
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

6.  Overexpression of GFAT activates PAI-1 promoter in mesangial cells.

Authors:  L R James; I G Fantus; H Goldberg; H Ly; J W Scholey
Journal:  Am J Physiol Renal Physiol       Date:  2000-10

7.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation.

Authors:  X L Du; D Edelstein; L Rossetti; I G Fantus; H Goldberg; F Ziyadeh; J Wu; M Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

8.  Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.

Authors:  Y Gao; L Wells; F I Comer; G J Parker; G W Hart
Journal:  J Biol Chem       Date:  2001-01-08       Impact factor: 5.157

9.  Effects of glucosamine infusion on insulin secretion and insulin action in humans.

Authors:  T Monauni; M G Zenti; A Cretti; M C Daniels; G Targher; B Caruso; M Caputo; D McClain; S Del Prato; A Giaccari; M Muggeo; E Bonora; R C Bonadonna
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

10.  High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes.

Authors:  B A Nelson; K A Robinson; M G Buse
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

View more
  157 in total

1.  Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.

Authors:  John C Chatham; Richard B Marchase
Journal:  Curr Signal Transduct Ther       Date:  2010-01

Review 2.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

3.  O-GlcNAc-ylation in the Nuclear Pore Complex.

Authors:  Andrew Ruba; Weidong Yang
Journal:  Cell Mol Bioeng       Date:  2016-04-26       Impact factor: 2.321

4.  Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.

Authors:  Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 5.  Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.

Authors:  Norbert Fülöp; Richard B Marchase; John C Chatham
Journal:  Cardiovasc Res       Date:  2006-07-29       Impact factor: 10.787

Review 6.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

Review 7.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

Review 8.  The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.

Authors:  Richard D Semba; Hu Huang; Gerard A Lutty; Jennifer E Van Eyk; Gerald W Hart
Journal:  Proteomics Clin Appl       Date:  2014-02-19       Impact factor: 3.494

9.  mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1.

Authors:  Joseph G Moloughney; Peter K Kim; Nicole M Vega-Cotto; Chang-Chih Wu; Sisi Zhang; Matthew Adlam; Thomas Lynch; Po-Chien Chou; Joshua D Rabinowitz; Guy Werlen; Estela Jacinto
Journal:  Mol Cell       Date:  2016-08-25       Impact factor: 17.970

10.  Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.

Authors:  Stephen A Whelan; Wagner B Dias; Lakshmanan Thiruneelakantapillai; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.